Kawasaki Disease - 21 Studies Found

Withdrawn : Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease
: Kawasaki Disease
: 2006-03-20
: Drug: pravastatin
Completed : Etiology Study of Kawasaki Disease
: Kawasaki Disease
: 2005-09-09
Completed : Infliximab (Remicade) for Patients With Acute Kawasaki Disease
: Kawasaki Disease
: 2005-12-30
:
  • Drug: Infliximab (Remicade) Re
Completed : Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
: Kawasaki Disease
: 2012-01-25
: Drug: immunoglobulin G Intravenously administer a single dose of the product (2g/kg) for at least 12 hou
Completed : A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
: Kawasaki Disease
: 2005-09-09
: Drug: Sestamibi Sestamibi Other Name: Cardiolite
Active, not recruiting : Etanercept in Kawasaki Disease
:
  • Mucocutaneous Lymph Node Syndrome
  • Kawasak
    : 2009-02-10
    :
    • Drug: Etanercept etanercept 0.
Completed : KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
: Mucocutaneous Lymph Node Syndrome
: 2017-01-17
:
  • Drug: IVIG Subjects randomized
Completed : Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
: Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
: 2012-05-09
:
  • Drug: TA-650 TA-650 at 5 mg pe
Completed : Safety and Vascular Remodelling After BVS Implantation for Stenotic or Occluded Lesions in Children and Young Adults With KD.
: Kawasaki Disease
: 2016-05-05
: Device: Bioresorbable Vascular Scaffold
Completed : A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
: Kawasaki Disease
: 2005-09-09
: Drug: Technetium Tc99m Sestamibi Rest and/or stress SPECT imaging study
<<< Previous | Next >>>